Companies / Santa Cruz Biotechnology / IKKα (B-8) FITC
Santa Cruz Biotechnology

IKKα (B-8) FITC | Santa Cruz Biotechnology

mouse monoclonal IgG2b; IKKα Antibody (B-8) is an IgG2b κ mouse monoclonal IKK alpha antibody (also designated IKK alpha antibody, IKK1 antibody, IKKA antibody, CHUK antibody or NFKBIKA antibody) that detects the IKK alpha protein of human origin by WB, IP, IF, IHC(P), FCM and ELISA. IKKα Antibody (B-8) is available as both the non-conjugated anti-IKK alpha antibody form, as well as multiple conjugated forms of anti-IKK alpha antibody, including agarose, HRP, PE, FITC and multiple Alexa Fluor® conjugates. The transcription factor NFkB is retained in the cytoplasm in an inactive form by the inhibitory protein IkB. Activation of NFkB requires that IkB be phosphorylated on specific serine residues, which results in targeted degradation of IkB. IkB kinase a (IKKa), previously designated CHUK, interacts with IkB-a and specifically phosphorylates IkB-a on Ser 32 and 36, the sites that trigger its degradation. IKKa appears to be critical for NFkB activation in response to proinflammatory cytokines. Phosphorylation of IkB by IKKa is stimulated by the NFkB inducing kinase (NIK), which itself is a central regulator for NFkB activation in response to TNF and IL-1. The functional IKK complex contains three subunits, IKKa, IKKb and IKKg (also designated NEMO), and each appear to make essential contributions to IkB phosphorylation.

Reviews


No reviews yet

ABOUT THE COMPANY

Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past 30+ years, the Company has focused on the ongoing development of research antibodies, siRNA and CRISPR Gene editing tools, biochemicals, labware and more recently has expanded into animal health care products. Santa Cruz Biotechnology has the highest commitment to quality and customer service.